Evidence | Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | Guidance | NICE

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

Surveillance report
2022 exceptional surveillance of familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (NICE guideline CG164)
Appendix A: Stakeholder consultation comments table ^{PDF 550 KB} 09 June 2022
2019 exceptional surveillance of familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (NICE guideline CG164)
Surveillance report 2018 – Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (2013) NICE guideline CG164
Appendix A: Summary of evidence from surveillance ^{PDF 1.03 MB} 18 January 2018
Appendix B: Stakeholder consultation comments table ^{PDF 425 KB} 18 January 2018
Surveillance review decision - November 2015 ^{PDF 226 KB} 18 November 2015
Surveillance review decision matrix - November 2015 ^{PDF 280 KB} 18 November 2015
Full guidance
Full guideline ^{PDF 2.15 MB} 22 March 2017
Full guideline appendices E-G ^{PDF 553 KB} 22 March 2017
Clinical evidence review ^{PDF 6.92 MB} 22 March 2017
Cost effectiveness evidence review ^{PDF 4.88 MB} 22 March 2017
Needs assessment ^{PDF 1.12 MB} 22 March 2017
Addendum ^{PDF 3.91 MB} 22 March 2017